In 6 patients with Sjogren-Larsson syndrome (SL), the urinary excretion of
leukotriene B-4 (LTB4) and omega-hydroxy-LTB4 was found to be highly elevat
ed, whereas omega-carboxy-LTB4 was absent. This abnormal pattern of urinary
excretion of LTB4 and its metabolites appears to be unique to patients wit
h SLS and offers a new approach to the diagnosis of this disorder. Moreover
, defective inactivation of LTB4 might be of pathophysiologic significance
in the disease.